SWAV vs. INSP, CMD, NARI, RMD, WST, BAX, PODD, SOLV, TFX, and GMED
Should you be buying Shockwave Medical stock or one of its competitors? The main competitors of Shockwave Medical include Inspire Medical Systems (INSP), Cantel Medical (CMD), Inari Medical (NARI), ResMed (RMD), West Pharmaceutical Services (WST), Baxter International (BAX), Insulet (PODD), Solventum (SOLV), Teleflex (TFX), and Globus Medical (GMED). These companies are all part of the "medical" sector.
Inspire Medical Systems (NYSE:INSP) and Shockwave Medical (NASDAQ:SWAV) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, community ranking, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.
Shockwave Medical has higher revenue and earnings than Inspire Medical Systems. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Shockwave Medical, indicating that it is currently the more affordable of the two stocks.
Shockwave Medical has a net margin of 20.75% compared to Shockwave Medical's net margin of -2.38%. Inspire Medical Systems' return on equity of 24.79% beat Shockwave Medical's return on equity.
Inspire Medical Systems has a beta of 1.35, meaning that its share price is 35% more volatile than the S&P 500. Comparatively, Shockwave Medical has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500.
94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 95.4% of Shockwave Medical shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by insiders. Comparatively, 3.4% of Shockwave Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Inspire Medical Systems presently has a consensus target price of $256.53, indicating a potential upside of 62.41%. Shockwave Medical has a consensus target price of $309.11, indicating a potential downside of 7.60%. Given Shockwave Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Inspire Medical Systems is more favorable than Shockwave Medical.
Inspire Medical Systems received 43 more outperform votes than Shockwave Medical when rated by MarketBeat users. Likewise, 61.03% of users gave Inspire Medical Systems an outperform vote while only 55.83% of users gave Shockwave Medical an outperform vote.
In the previous week, Shockwave Medical had 10 more articles in the media than Inspire Medical Systems. MarketBeat recorded 19 mentions for Shockwave Medical and 9 mentions for Inspire Medical Systems. Shockwave Medical's average media sentiment score of 1.26 beat Inspire Medical Systems' score of 0.67 indicating that Inspire Medical Systems is being referred to more favorably in the media.
Summary
Shockwave Medical beats Inspire Medical Systems on 10 of the 18 factors compared between the two stocks.
Get Shockwave Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for SWAV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SWAV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Shockwave Medical Competitors List
Related Companies and Tools
